Agonist trigger: What is the best approach? Agonist trigger with aggressive luteal support

Fertility and Sterility

Volumn 97, Issue 3, 2012, Pages 531-533

  Engmann, Lawrence ^a   Benadiva, Claudio ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

dual GnRHa trigger; GnRHa trigger; low dose hCG supplementation; luteal phase support; OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN RECEPTOR; ESTROGEN; GONADORELIN AGONIST; PROGESTERONE;

CORPUS LUTEUM FUNCTION; DRUG DOSE INCREASE; EMBRYO TRANSFER; ENDOMETRIUM; FERTILIZATION IN VITRO; GESTATION PERIOD; GESTATIONAL AGE; HORMONAL CONTRACEPTION; HUMAN; IMPLANTATION; LOW DRUG DOSE; LUTEAL PHASE; LUTEAL PHASE SUPPORT; OOCYTE MATURATION; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; TREATMENT RESPONSE;

EID: 84857789622     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.12.020     Document Type: Article

References (26)

1. P. Humaidan, S. Kol, and E. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod Update 17 2011 510 524
2. L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study Fertil Steril 89 2008 84 91
3. N. Kummer, C. Benadiva, R. Feinn, J. Mann, J. Nulsen, and L. Engmann Factors that predict the probability of a successful clinical outcome after induction of oocyte maturation with a gonadotropin-releasing hormone agonist Fertil Steril 96 2011 63 68
4. J. Itskovitz, R. Boldes, J. Levron, Y. Erlik, L. Kahana, and J.M. Brandes Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist Fertil Steril 56 1991 213 220
5. M.B. Zelinski-Wooten, S.E. Lanzendorf, D.P. Wolf, Y.A. Chandrasekher, and R.L. Stouffer Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. I. Oocyte maturation and corpus luteum function J Clin Endocrinol Metab 73 1991 577 583
6. M.B. Zelinski-Wooten, J.S. Hutchison, Y.A. Chandrasekher, D.P. Wolf, and R.L. Stouffer Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles J Clin Endocrinol Metab 75 1992 502 507
7. Y.A. Chandrasekher, R.M. Brenner, T.A. Molskness, Q. Yu, and R.L. Stouffer Titrating luteinizing hormone surge requirements for ovulatory changes in primate follicles. II. Progesterone receptor expression in luteinizing granulosa cells J Clin Endocrinol Metab 73 1991 584 589
8. N.G. Beckers, N.S. Macklon, M.J. Eijkemans, M. Ludwig, R.E. Felberbaum, and K. Diedrich Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment J Clin Endocrinol Metab 88 2003 4186 4192
9. L. Engmann, L. Siano, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod Biomed Online 13 2006 639 644
10. R. Babayof, E.J. Margalioth, M. Huleihel, A. Amash, E. Zylber-Haran, and M. Gal Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial Hum Reprod 21 2006 1260 1265
11. O. Nevo, T. Eldar-Geva, S. Kol, and J. Itskovitz-Eldor Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin Fertil Steril 79 2003 1123 1128
12. B. Acevedo, J.L. Gomez-Palomares, E. Ricciarelli, and E.R. Hernandez Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates Fertil Steril 86 2006 1682 1687
13. Hernández ER G-PJ, Ricciarelli E. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil Steril 2009;91:1358-61.
14. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
15. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
16. L. Engmann, and C. Benadiva Ovarian hyperstimulation syndrome prevention strategies Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasinghormone agonist ovulatory trigger Semin Reprod Med 28 2010 506 512
17. C.K. Cheng, and P.C. Leung Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans Endocr Rev 26 2005 283 306
18. S. Daya Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles Cochrane Database Syst Rev 2000 CD001299
19. J. Tesarik, A. Hazout, and C. Mendoza Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation Hum Reprod 19 2004 1176 1180
20. A.Z. Isik, G.S. Caglar, E. Sozen, C. Akarsu, G. Tuncay, and T. Ozbicer Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study Reprod Biomed Online 19 2009 472 477
21. J.B. Oliveira, R. Baruffi, C.G. Petersen, A.L. Mauri, M. Cavagna, and J.G. Franco Jr Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis Reprod Biol Endocrinol 8 2010 107
22. P. Licht, V. Russu, S. Lehmeyer, and L. Wildt Molecular aspects of direct LH/hCG effects on human endometrium - lessons from intrauterine microdialysis in the human female in vivo Reprod Biol 1 2001 10 19
23. T.H. Wang, S.G. Horng, C.L. Chang, H.M. Wu, Y.J. Tsai, and H.S. Wang Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor J Clin Endocrinol Metab 87 2002 3300 3308
24. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and C. Hudson Comparison of "triggers" using leuprolide acetate alone or in combination with low-dosehuman chorionic gonadotropin Fertil Steril 95 2011 2715 2717
25. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, and S. Thomas Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization Fertil Steril 90 2008 231 233
26. D.W. Griffin, C.A. Benadiva, N.E. Kummer, A.A. Elassar, J.C. Nulsen, and L.L. Engmann Dual trigger of oocyte maturation with gonadotropin releasing hormone agonist (GnRHa) and low dose human chorionic gonadotropin (hCG) to optimize conception rates in high responders Fertil Steril 96 2011 S20